Training and Continuing Education
Welcome to CDERLearn, the web page for educational tutorials offered by the Center for Drug Evaluation and Research (CDER). CDER's primary mission is to make certain that safe and effective drugs are available to the American people. There is, however, a strategic initiative to inform and educate people about the safe use of medicine, the drug regulatory process, the vital role health care professionals play to assist FDA in fulfilling its duties, and many other important issues. Online training is one way to share FDA expertise with many more people than face-to-face classroom sessions would allow, and we will offer additional CDERLearn courses in the future.
- The FDA Bad Ad Program and Prescription Drug Promotion
This self-paced Web education course is designed to raise awareness among health care professionals (HCPs) about prescription drug promotion that may be misleading and educates HCPs about how to easily report these problems to FDA's Office of Prescription Drug Promotion.
- Small Business Education Series
CDER's Small Business Assistance Program has developed a series of Web-based courses to educate regulated small pharmaceutical industry.
- The Past, Present, and Future of FDA Human Drug Regulation
An updated version of "Drug Review and Related Activities in the United States," with continuing education (CE) credit for pharmacists, physicians, and nurses (see Accreditation link for specific CE expiration dates). The program gives health care professionals, industry, consumers, and all other interested participants an overview of the human drug regulatory process in the United States. Course time: approximately 90 minutes
- Medicines in My Home -An Interactive Home
This educational program is designed to help consumers from adolescence to adulthood understand and use the Drug Facts label to choose over-the-counter medicines and use them safely.
- Risk Assessment and Communication
This CME program offered through Discover Health explains ways that physicians can communicate risk to their patients to help them make informed health care decisions. Available for credit through June 27, 2011
- FDA Medwatch and Patient Safety
An online tutorial covering the MedWatch program goals of broadcasting safety information and encouraging adverse event reporting
- Field Investigators: Adverse Drug Effects (ADE) Investigators (2000)
- The FDA Process for Approving Generic Drugs
Credit is no longer available for this course.
- An Introduction to the Improved FDA Prescription Drug Labeling
Credit is no longer available for this course. The primary audience for this course content is physicians, physician assistants, pharmacists, nurses, nurse practitioners, and dentists. Secondary audiences include other health practitioners who are interested in the revised prescription drug labeling.